These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28052094)

  • 21. Association of susceptibility locus for inflammatory bowel disease on chromosome 16 with both ulcerative colitis and Crohn's disease.
    Farmer M; Hunt L; Eichenberger MR; Petras RE; Janosky JE; Galandiuk S
    Dig Dis Sci; 2001 Mar; 46(3):632-6. PubMed ID: 11318544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candidate polymorphisms and susceptibility to inflammatory bowel disease: A systematic review and meta-analysis.
    Tang L; Xu M
    Gene; 2020 Aug; 753():144814. PubMed ID: 32464244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTLA4 CT60 single-nucleotide polymorphism is associated with Slovenian inflammatory bowel disease patients and regulates expression of CTLA4 isoforms.
    Repnik K; Potocnik U
    DNA Cell Biol; 2010 Oct; 29(10):603-10. PubMed ID: 20491567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of the genetic polymorphisms of antioxidant enzymes on susceptibility to papillary thyroid carcinoma.
    Salimi S; Harati-Sadegh M; Eskandari M; Heidari Z
    IUBMB Life; 2020 May; 72(5):1045-1053. PubMed ID: 32031754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease.
    Tremelling M; Cummings F; Fisher SA; Mansfield J; Gwilliam R; Keniry A; Nimmo ER; Drummond H; Onnie CM; Prescott NJ; Sanderson J; Bredin F; Berzuini C; Forbes A; Lewis CM; Cardon L; Deloukas P; Jewell D; Mathew CG; Parkes M; Satsangi J
    Gastroenterology; 2007 May; 132(5):1657-64. PubMed ID: 17484863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
    Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
    Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease.
    D'Amato M; Bruce S; Bresso F; Zucchelli M; Ezer S; Pulkkinen V; Lindgren C; Astegiano M; Rizzetto M; Gionchetti P; Riegler G; Sostegni R; Daperno M; D'Alfonso S; Momigliano-Richiardi P; Torkvist L; Puolakkainen P; Lappalainen M; Paavola-Sakki P; Halme L; Farkkila M; Turunen U; Kontula K; Lofberg R; Pettersson S; Kere J
    Gastroenterology; 2007 Sep; 133(3):808-17. PubMed ID: 17854592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of MYO9B gene polymorphisms with inflammatory bowel disease in Chinese Han population.
    Hu J; Mei Q; Huang J; Hu NZ; Liu XC; Xu JM
    World J Gastroenterol; 2014 Jun; 20(23):7466-72. PubMed ID: 24966617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical predictors of inflammatory bowel disease in a genetically well-defined Caucasian population.
    Kanaan ZM; Eichenberger MR; Ahmad S; Weller C; Roberts H; Pan J; Rai SN; Petras R; Weller EB; Galandiuk S
    J Negat Results Biomed; 2012 Jan; 11():7. PubMed ID: 22269043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
    Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
    Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.
    Sventoraityte J; Zvirbliene A; Franke A; Kwiatkowski R; Kiudelis G; Kupcinskas L; Schreiber S
    World J Gastroenterol; 2010 Jan; 16(3):359-64. PubMed ID: 20082483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background.
    Glas J; Wagner J; Seiderer J; Olszak T; Wetzke M; Beigel F; Tillack C; Stallhofer J; Friedrich M; Steib C; Göke B; Ochsenkühn T; Karbalai N; Diegelmann J; Czamara D; Brand S
    PLoS One; 2012; 7(3):e33682. PubMed ID: 22457781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective association of TNFSF15 polymorphisms with Crohn's disease and ulcerative colitis: A meta-analysis.
    He L; Chen J; Sun J; Peng J; He Q
    Saudi J Gastroenterol; 2018; 24(4):201-210. PubMed ID: 29873318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
    Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
    Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship.
    Anderson CA; Massey DC; Barrett JC; Prescott NJ; Tremelling M; Fisher SA; Gwilliam R; Jacob J; Nimmo ER; Drummond H; Lees CW; Onnie CM; Hanson C; Blaszczyk K; Ravindrarajah R; Hunt S; Varma D; Hammond N; Lewis G; Attlesey H; Watkins N; Ouwehand W; Strachan D; McArdle W; Lewis CM; ; Lobo A; Sanderson J; Jewell DP; Deloukas P; Mansfield JC; Mathew CG; Satsangi J; Parkes M
    Gastroenterology; 2009 Feb; 136(2):523-9.e3. PubMed ID: 19068216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of
    Jerotic D; Matic M; Suvakov S; Vucicevic K; Damjanovic T; Savic-Radojevic A; Pljesa-Ercegovac M; Coric V; Stefanovic A; Ivanisevic J; Jelic-Ivanovic Z; McClements L; Dimkovic N; Simic T
    Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31340563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between toll-like receptors/CD14 gene polymorphisms and inflammatory bowel disease in Korean population.
    Kim EJ; Chung WC; Lee KM; Paik CN; Jung SH; Lee BI; Chae HS; Choi KY
    J Korean Med Sci; 2012 Jan; 27(1):72-7. PubMed ID: 22219617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDR1 gene polymorphisms are associated with ulcerative colitis in a cohort of Serbian patients with inflammatory bowel disease.
    Mijac D; Vukovic-Petrovic I; Mijac V; Perovic V; Milic N; Djuranovic S; Bojic D; Popovic D; Culafic D; Krstic M; Jankovic G; Pravica V; Markovic M
    PLoS One; 2018; 13(3):e0194536. PubMed ID: 29543864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.